Glofitamab in Relapsed/Refractory Mantle Cell Lymphoma: Results from a Phase I/II Study
JOURNAL OF CLINICAL ONCOLOGY(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined